Lista de obras - Robert Pytlik - Dominio Público Uruguay

A new prognostic score for elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: the prognostic role of blood monocyte and lymphocyte counts is absent

artículo científico publicado en 2014

Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma.

artículo científico publicado en 2017

Analysis of risk factors: the rationale of the guidelines of the Czech Hematological Society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia

artículo científico publicado en 2006

Can Rituximab Improve the Outcome of Patients with Nodular Lymphocyte-Predominant Hodgkin's Lymphoma?

scientific article published on 27 May 2015

Characterization of dental pulp stem cells from impacted third molars cultured in low serum-containing medium

scientific article published on 11 November 2010

Circulating endothelial progenitor cells in patients with ANCA-associated vasculitis

scientific article published on 04 July 2008

Detection of cell type and marker specificity of nuclear binding sites for anionic carbohydrate ligands.

artículo científico publicado en 2004

Distinguishing of primary mediastinal B-cell lymphoma and diffuse large B-cell lymphoma using real-time quantitative polymerase chain reaction

artículo científico publicado en 2010

Evaluation of sericin as a fetal bovine serum-replacing cryoprotectant during freezing of human mesenchymal stromal cells and human osteoblast-like cells.

artículo científico publicado en 2014

Expression of genes regulating angiogenesis in human circulating hematopoietic cord blood CD34+/CD133+ cells.

artículo científico publicado en 2003

High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis.

artículo científico publicado en 2000

Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database.

artículo científico publicado en 2015

Individually determined dosing of filgrastim after autologous peripheral stem cell transplantation in patients with malignant lymphoma--results of a prospective multicentre controlled trial

artículo científico publicado en 2006

Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction: a prematurely terminated randomized study

scientific article published on 04 June 2007

Long-term outcomes of older patients with relapsed/refractory NHL referred to ASCT

artículo científico publicado en 2020

New aspects of galectin functionality in nuclei of cultured bone marrow stromal and epidermal cells: biotinylated galectins as tool to detect specific binding sites

artículo científico publicado en 2003

Pre-transplant positron emission tomography in patients with relapsed Hodgkin lymphoma

artículo científico publicado en 2011

Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?

artículo científico publicado en 2014

Reply to the letter to the editor by Guinn et al

artículo científico publicado en 2011

Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Databa

artículo científico publicado en 2013

Rituximab based therapy followed by autologous stem cell transplantation leads to superior outcome and high rates of PCR negativity in patients with indolent B-cell lymphoproliferative disorders

scientific article published on 01 August 2009

Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry

scientific article published on 18 April 2016

Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2- and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma.

artículo científico publicado en 2015

The Hans algorithm failed to predict outcome in patients with diffuse large B-cell lymphoma treated with rituximab.

artículo científico publicado en 2013

The Impact of Various Culture Conditions on Human Mesenchymal Stromal Cells Metabolism

artículo científico publicado en 2021

The WHO 2008 classification of Ph-myeloproliferative disorders: statement of the Czech MPD Working Group

scientific article published on 17 April 2008

The evaluation of survival and proliferation of lymphocytes in autologous mixed leukocyte reaction with dendritic cells. The comparison of incorporation of (3)H-thymidine and differential gating method

scientific article published on 06 July 2011

The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database

artículo científico publicado en 2018

The role of apoptosis in cancer development and treatment: focusing on the development and treatment of hematologic malignancies.

scientific article published on January 2010

Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation

artículo científico publicado en 2010

Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial.

artículo científico publicado en 2014

Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma: report of the pivotal phase 2 study.

artículo científico publicado en 2009

Lista de obras de Robert Pytlik

A new prognostic score for elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: the prognostic role of blood monocyte and lymphocyte counts is absent

Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma.

Analysis of risk factors: the rationale of the guidelines of the Czech Hematological Society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia

Can Rituximab Improve the Outcome of Patients with Nodular Lymphocyte-Predominant Hodgkin's Lymphoma?

Characterization of dental pulp stem cells from impacted third molars cultured in low serum-containing medium

Circulating endothelial progenitor cells in patients with ANCA-associated vasculitis

Detection of cell type and marker specificity of nuclear binding sites for anionic carbohydrate ligands.

Distinguishing of primary mediastinal B-cell lymphoma and diffuse large B-cell lymphoma using real-time quantitative polymerase chain reaction

Evaluation of sericin as a fetal bovine serum-replacing cryoprotectant during freezing of human mesenchymal stromal cells and human osteoblast-like cells.

Expression of genes regulating angiogenesis in human circulating hematopoietic cord blood CD34+/CD133+ cells.

High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis.

Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database.

Individually determined dosing of filgrastim after autologous peripheral stem cell transplantation in patients with malignant lymphoma--results of a prospective multicentre controlled trial

Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction: a prematurely terminated randomized study

Long-term outcomes of older patients with relapsed/refractory NHL referred to ASCT

New aspects of galectin functionality in nuclei of cultured bone marrow stromal and epidermal cells: biotinylated galectins as tool to detect specific binding sites

Pre-transplant positron emission tomography in patients with relapsed Hodgkin lymphoma

Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?

Reply to the letter to the editor by Guinn et al

Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Databa

Rituximab based therapy followed by autologous stem cell transplantation leads to superior outcome and high rates of PCR negativity in patients with indolent B-cell lymphoproliferative disorders

Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry

Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2- and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma.

The Hans algorithm failed to predict outcome in patients with diffuse large B-cell lymphoma treated with rituximab.

The Impact of Various Culture Conditions on Human Mesenchymal Stromal Cells Metabolism

The WHO 2008 classification of Ph-myeloproliferative disorders: statement of the Czech MPD Working Group

The evaluation of survival and proliferation of lymphocytes in autologous mixed leukocyte reaction with dendritic cells. The comparison of incorporation of (3)H-thymidine and differential gating method

The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database

The role of apoptosis in cancer development and treatment: focusing on the development and treatment of hematologic malignancies.

Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation

Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial.

Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma: report of the pivotal phase 2 study.